Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes

Coyle-Gilchrist, Ian T. S. ORCID: https://orcid.org/0000-0001-8887-1801, Dick, Katrina M., Patterson, Karalyn, Rodríquez, Patricia Vázquez, Wehmann, Eileen, Wilcox, Alicia, Lansdall, Claire J., Dawson, Kate E., Wiggins, Julie, Mead, Simon, Brayne, Carol and Rowe, James B. (2016) Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology, 86 (18). pp. 1736-1743. ISSN 0028-3878

Full text not available from this repository. (Request a copy)

Abstract

Objectives: To estimate the lifetime risk, prevalence, incidence, and mortality of the principal clinical syndromes associated with frontotemporal lobar degeneration (FTLD) using revised diagnostic criteria and including intermediate clinical phenotypes. Methods: Multisource referral over 2 years to identify all diagnosed or suspected cases of frontotemporal dementia (FTD), progressive supranuclear palsy (PSP), or corticobasal syndrome (CBS) in 2 UK counties (population 1.69 million). Diagnostic confirmation used current consensus diagnostic criteria after interview and reexamination. Results were adjusted to the 2013 European standard population. Results: The prevalence of FTD, PSP, and CBS was 10.8/100,000. The incidence and mortality were very similar, at 1.61/100,000 and 1.56/100,000 person-years, respectively. The estimated lifetime risk is 1 in 742. Survival following diagnosis varied widely: from PSP 2.9 years to semantic variant FTD 9.1 years. Age-adjusted prevalence peaked between 65 and 69 years at 42.6/100,000: the age-adjusted prevalence for persons older than 65 years is double the prevalence for those between 40 and 64 years. Fifteen percent of those screened had a relevant genetic mutation. Conclusions: Key features of this study include the revised diagnostic criteria with improved specificity and sensitivity, an unrestricted age range, and simultaneous assessment of multiple FTLD syndromes. The prevalence of FTD, PSP, and CBS increases beyond 65 years, with frequent genetic causes. The time from onset to diagnosis and from diagnosis to death varies widely among syndromes, emphasizing the challenge and importance of accurate and timely diagnosis. A high index of suspicion for FTLD syndromes is required by clinicians, even for older patients.

Item Type: Article
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 12 May 2023 11:31
Last Modified: 15 May 2023 09:31
URI: https://ueaeprints.uea.ac.uk/id/eprint/92027
DOI: 10.1212/WNL.0000000000002638

Actions (login required)

View Item View Item